Table III.
Clinical outcome preoperative (pre) and postoperative (post) after short-stem RSA.
| Study | Prosthesis type | Shoulders, n | FU months, mean (range) | ROM pre | ROM pre (SD) | ROM post | ROM post (SD) | Pain pre (SD) | Pain post (SD) | Outcome score pre (SD) | Outcome score post (SD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Giuseffi (2013)19 | Comprehensive Reverse System Mini Stem | 44 | 27 (24-40) | Flex: 54 ER: 14 | Flex: 20 ER 13 | Flex: 142 ER: 45 | Flex: 25 ER: 9 | NR | Mild/none in 43 shoulders (97.7%) | NR | NR |
| Atoun (2014)5 | Verso Reverse Shoulder Prosthesis | 31 | 36 (24-52) | Flex: 47 Abd: 42 | NR | Flex: 129 Abd: 117 ER: 51 | NR | CS: 0.8 | CS: 12.5 | CS: 12.7 CS (%): 17.8 | CS: 56.2, CS (%): 80.2 |
| Ascione (2017)2 | Ascend Flex | 100 | 32,6 (24-44) | Flex: 82 ER: 5.6 | Flex: 31 ER: 24 | Flex: 141 ER: 25 | Flex: 25 ER: 20 | NR | NR | CS: 25.5 (8.8) SSV: 28 | CS: 69.7 (14.4) SSV: 76 |
| Goetzmann (2017)20 | Ascend Flex | 24 | 25,6∗(24-30.8) | Flex: 79 Abd: 63 ER: 10 | Flex: 29 Abd: 24 ER: 16 | Flex: 139 Abd: 122 ER: 28 | Flex: 23 Abd: 27 ER 12 | CS: 3 (3) | CS: 12 (3) | CS: 22 (7) | CS: 63 (11) |
| Schnetzke (2017)48 | Ascend Flex | 24 | 25∗(20-35) | Flex: 62 Abd: 59 ER: 12 | Flex: 26 Abd: 27 ER: 31 | Flex: 119 Abd: 125 ER: 23 | Flex: 43 Abd: 41 ER: 19 | CS: 5.6 (4.2) | CS: 13.7 (2.6) | CS: 21.7 (12.9) CS (%): 28.8 (17.2) SSV: 35.1 (21.4) | CS: 57.1 (18.4) CS (%): 76.1 (24.5) SSV: 66.4 (23.4) |
| Merolla (2017)36 | Ascend Flex | 38 | 29,1 (24-31) | Flex: 83 Abd: 74 ER: 0 | NR | Flex: 142 Abd: 131 ER: 32 | NR | VAS: 8.5 | VAS: 0.8 | CS: 27 | CS: 71.2 |
| Aibinder (2019)1 | Comprehensive Reverse System Micro Stem | 65 | 45,6∗ (36-99.6) | Flex: 70 ER: 24 | NR | Flex: 129 ER: 40 | NR | NR | NR | NR | NR |
| Dukan (2019)13 | Ascend Flex | 71 | 38,8 | Flex: 89 ER: 25 | Flex: 19 ER: 10 | Flex: 131 ER: 36 | Flex: 20 ER: 8 | NR | NR | CS: 44.2 (11.2) VAS: 6.8 (1.1) ASES: 36.2 (5.3) | CS: 87.9 (11.6) VAS: 0.4 (0.9) ASES: 84.3 (9.4) |
| Raiss (2019)42 | Ascend Flex | 77 | 28 (24-48) | NR | NR | NR | NR | NR | NR | NR | NR |
| Peduzzi (2019)40 | Ascend Flex | 81 | 27,5∗ (23-47) | Flex: 84 Abd: 80 ER: 18 | Flex: 36 Abd: 28 ER: 22 | Flex: 131 Abd: 111 ER: 28 | Flex: 21 Abd: 27 ER: 20 | CS: 7.9 (12.2) | CS: 13.1 (3.2) | CS: 31 (13) | CS: 62 (11) |
| Weighted means | 33 | Flex: 76 Abd: 68 ER: 15 | Flex: 134 Abd: 119 ER: 32 | CS: 5.4 | CS: 12.9 | CS: 28.9 CS (%): 22.6 SSV: 29.4 | CS: 69.3 CS (%): 78.4 SSV (%): 74.1 |
FU, follow-up; RSA, reverse shoulder arthroplasty; ROM, range of motion; Flex, flexion; Abd, abduction; ER, external rotation; CS, Constant score; CS (%), age- and gender-adjusted CS; SSV, subjective shoulder value; VAS, visual analog scale; ASES, American Shoulder and Elbow Surgeons shoulder score; NR, not reported; SD, standard deviation.
∗
Reported FU for both intervention groups.